|
1
|
Tsikouras P, Bouchlariotou S, Vrachnis N,
Dafopoulos A, Galazios G, Csorba R and von Tempelhoff GF:
Endometrial cancer: Molecular and therapeutic aspects. Eur J Obstet
Gynecol Reprod Biol. 169:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center M M, Ferlay J,
Ward E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Llobet D, Pallares J, Yeramian A,
Santacana M, Eritja N, Velasco A, Dolcet X and Matias-Guiu X:
Molecular pathology of endometrial carcinoma: Practical aspects
from the diagnostic and therapeutic viewpoints. J Clin Pathol.
62:777–785. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chaudhry P and Asselin E: Resistance to
chemotherapy and hormone therapy in endometrial cancer. Endocr
Relat Cancer. 16:363–380. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sherman ME, Sturgeon S, Brinton L and
Kurman RJ: Endometrial cancer chemoprevention: Implications of
diverse pathways of carcinogenesis. J Cell Biochem Suppl.
23:160–164. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mutter GL, Lin MC, Fitzgerald JT, Kum JB,
Baak JP, Lees JA, Weng LP and Eng C: Altered PTEN expression as a
diagnostic marker for the earliest endometrial precancers. J Natl
Cancer Inst. 92:924–930. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ryan AJ, Susil B, Jobling TW and Oehler
MK: Endometrial cancer. Cell Tissue Res. 322:53–61. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hajjari M, Khoshnevisan A and Shin YK:
Molecular function and regulation of non-coding RNAs: Paradigms
with potential roles in cancer. Tumour Biol. 35:10645–10663. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang KC, Yang YW, Liu B, Sanyal A,
Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta
RA, et al: A long noncoding RNA maintains active chromatin to
coordinate homeotic gene expression. Nature. 472:120–124. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jia H, Osak M, Bogu GK, Stanton LW,
Johnson R and Lipovich L: Genome-wide computational identification
and manual annotation of human long noncoding RNA genes. RNA.
16:1478–1487. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hung T and Chang HY: Long noncoding RNA in
genome regulation: Prospects and mechanisms. RNA Biol. 7:582–585.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guenther MG, Levine SS, Boyer LA, Jaenisch
R and Young RA: A chromatin landmark and transcription initiation
at most promoters in human cells. Cell. 130:77–88. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guttman M, Donaghey J, Carey BW, Garber M,
Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al:
LincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang YN, Zhang K, Hu ZM, Qi HX, Shi ZM,
Han XH, Han YW and Hong W: Hypoxia-regulated lncRNAs in cancer.
Gene. 575:1–8. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Heesch S, van Iterson M, Jacobi J,
Boymans S, Essers PB, de Bruijn E, Hao W, MacInnes AW, Cuppen E and
Simonis M: Extensive localization of long noncoding RNAs to the
cytosol and mono- and polyribosomal complexes. Genome Biol.
15:R62014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lujambio A, Akkari L, Simon J, Grace D,
Tschaharganeh DF, Bolden JE, Zhao Z, Thapar V, Joyce JA,
Krizhanovsky V and Lowe SW: Non-cell-autonomous tumor suppression
by p53. Cell. 153:449–460. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mellert H and Espinosa JM: Tumor
suppression by p53: Is apoptosis important or not? Cell Rep.
3:1335–1336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudogene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kotake Y, Nakagawa T, Kitagawa K, Suzuki
S, Liu N, Kitagawa M and Xiong Y: Long non-coding RNA ANRIL is
required for the PRC2 recruitment to and silencing of p15(INK4B)
tumor suppressor gene. Oncogene. 30:1956–1962. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yap KL, Li S, Muñoz-Cabello AM, Raguz S,
Zeng L, Mujtaba S, Gil J, Walsh MJ and Zhou MM: Molecular interplay
of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by
polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell.
38:662–674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Davidovich C and Cech TR: The recruitment
of chromatin modifiers by long noncoding RNAs: Lessons from PRC2.
RNA. 21:2007–2022. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vikram R, Ramachandran R and Abdul KS:
Functional significance of long non-coding RNAs in breast cancer.
Breast Cancer. 21:515–521. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang X, Ren Y, Yang X, Xiong X, Han S, Ge
Y, Pan W, Zhou L, Yuan Q and Yang M: miR-190a inhibits
epithelial-mesenchymal transition of hepatoma cells via targeting
the long non-coding RNA treRNA. FEBS Lett. 589:4079–4087. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhai W, Li X, Wu S, Zhang Y, Pang H and
Chen W: Microarray expression profile of lncRNAs and the
upregulated ASLNC04080 lncRNA in human endometrial carcinoma. Int J
Oncol. 46:2125–2137. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Doucrasy S, Coll J, Barrois M, Joubel A,
Prost S, Dozier C, Stehelin D and Riou G: Expression of the human
fetal bac h19 gene in invasive cancers. Int J Oncol. 2:753–758.
1993.PubMed/NCBI
|
|
32
|
Lottin S, Adriaenssens E, Berteaux N,
Leprêtre A, Vilain MO, Denhez E, Coll J, Dugimont T and Curgy JJ:
The human H19 gene is frequently overexpressed in myometrium and
stroma during pathological endometrial proliferative events. Eur J
Cancer. 41:168–177. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yan L, Zhou J, Gao Y, Ghazal S, Lu L,
Bellone S, Yang Y, Liu N, Zhao X, Santin AD, et al: Regulation of
tumor cell migration and invasion by the H19/let-7 axis is
antagonized by metformin-induced DNA methylation. Oncogene.
34:3076–3084. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tanos V, Ariel I, Prus D, De-Groot N and
Hochberg A: H19 and IGF2 gene expression in human normal,
hyperplastic and malignant endometrium. Int J Gynecol Cancer.
14:521–525. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang L, Zhang J, Jiang A, Liu Q, Li C,
Yang C and Xiu J: Expression profile of long non-coding RNAs is
altered in endometrial cancer. Int J Clin Exp Med. 8:5010–5021.
2015.PubMed/NCBI
|
|
36
|
Akrami R, Jacobsen A, Hoell J, Schultz N,
Sander C and Larsson E: Comprehensive analysis of long non-coding
RNAs in ovarian cancer reveals global patterns and targeted DNA
amplification. PLoS One. 12:e803062013. View Article : Google Scholar
|
|
37
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang Z, Zhou L, Wu LM, Lai MC, Xie HY,
Zhang F and Zheng SS: Overexpression of long non-coding RNA HOTAIR
predicts tumor recurrence in hepatocellular carcinoma patients
following liver transplantation. Ann Surg Oncol. 18:1243–1250.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim K, Jutooru I, Chadalapaka G, Johnson
G, Frank J, Burghardt R, Kim S and Safe S: HOTAIR is a negative
prognostic factor and exhibits pro-oncogenic activity in pancreatic
cancer. Oncogene. 32:1616–1625. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lv XB, Lian GY, Wang HR, Song E, Yao H and
Wang MH: Long noncoding RNA HOTAIR is a prognostic marker for
esophageal squamous cell carcinoma progression and survival. PLoS
One. 23:e635162013. View Article : Google Scholar
|
|
41
|
Niinuma T, Suzuki H, Nojima M, Nosho K,
Yamamoto H, Takamaru H, Yamamoto E, Maruyama R, Nobuoka T, Miyazaki
Y, et al: Upregulation of miR-196a and HOTAIR drive malignant
character in gastrointestinal stromal tumors. Cancer Res.
72:1126–1136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Huang J, Ke P, Guo L, Wang W, Tan H, Liang
Y and Yao S: Lentivirus-mediated RNA interference targeting the
long noncoding RNA HOTAIR inhibits proliferation and invasion of
endometrial carcinoma cells in vitro and in vivo. Int
J Gynecol Cancer. 24:635–642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
He X, Bao W, Li X, Chen Z, Che Q, Wang H
and Wan XP: The long non-coding RNA HOTAIR is upregulated in
endometrial carcinoma and correlates with poor prognosis. Int J Mol
Med. 33:325–332. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
You QY, Tao H and Ling B: Long noncoding
RNA HOX transcript antisense intergenic RNA (HOTAIR) as a foe and
novel potential therapeutic target for endometrial carcinoma. Int J
Gynecol Cancer. 24:15362014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhao Y, Yang Y, Trovik J, Sun K, Zhou L,
Jiang P, Lau TS, Hoivik EA, Salvesen HB, Sun H and Wang H: A novel
wnt regulatory axis in endometrioid endometrial cancer. Cancer Res.
74:5103–5117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lanz RB, Chua SS, Barron N, Söder BM,
DeMayo F and O'Malley BW: Steroid receptor RNA activator stimulates
proliferation as well as apoptosis in vivo. Mol Cell Biol.
23:7163–7176. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Baldinu P, Cossu A, Manca A, Satta MP,
Sini MC, Palomba G, Dessole S, Cherchi P, Mara L, Tanda F and
Palmieri G: CASC2a gene is down-regulated in endometrial cancer.
Anticancer Res. 27:235–243. 2007.PubMed/NCBI
|
|
49
|
Baldinu P, Cossu A, Manca A, Satta MP,
Sini MC, Rozzo C, Dessole S, Cherchi P, Gianfrancesco F, Pintus A,
et al: Identification of a novel candidate gene, CASC2, in a region
of common allelic loss at chromosome 10q26 in human endometrial
cancer. Hum Mutat. 23:318–326. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ying J, Li H, Seng TJ, Langford C,
Srivastava G, Tsao SW, Putti T, Murray P, Chan AT and Tao Q:
Functional epigenetics identifies a protocadherin PCDH10 as a
candidate tumor suppressor for nasopharyngeal, esophageal and
multiple other carcinomas with frequent methylation. Oncogene.
25:1070–1080. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhong X, Zhu Y, Mao J, Zhang J and Zheng
S: Frequent epigenetic silencing of PCDH10 by methylation in human
colorectal cancer. J Cancer Res Clin Oncol. 139:485–490. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Narayan G, Scotto L, Neelakantan V,
Kottoor SH, Wong AH, Loke SL, Mansukhani M, Pothuri B, Wright JD,
Kaufmann AM, et al: Protocadherin PCDH10, involved in tumor
progression, is a frequent and early target of promoter
hypermethylation in cervical cancer. Genes Chromosomes Cancer.
48:983–992. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhao Y, Yang Y, Trovik J, Sun K, Zhou L,
Jiang P, Lau TS, Hoivik EA, Salvesen HB, Sun H and Wang H: A novel
wnt regulatory axis in endometrioid endometrial cancer. Cancer Res.
74:5103–5117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhou X, Gao Q, Wang J, Zhang X, Liu K and
Duan Z: Linc-RNA-RoR acts as a ‘sponge’ against mediation of the
differentiation of endometrial cancer stem cells by microRNA-145.
Gynecol Oncol. 133:333–339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Gibb EA, Vucic EA, Enfield KS, Stewart GL,
Lonergan KM, Kennett JY, Becker-Santos DD, MacAulay CE, Lam S,
Brown CJ and Lam WL: Human cancer long non-coding RNA
transcriptomes. PLoS One. 6:e259152011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gutschner T, Hämmerle M and Diederichs S:
MALAT1-a paradigm for long noncoding RNA function in cancer. J Mol
Med (Berl). 91:791–801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Huang J, Ke P, Guo L, Wang W, Tan H, Liang
Y and Yao S: Lentivirus-mediated RNA interference targeting the
long noncoding RNA HOTAIR inhibits proliferation and invasion of
endometrial carcinoma cells in vitro and in vivo. Int J
Gynecol Cancer. 24:635–642. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Noer MC, Antonsen SL, Ottesen B,
Christensen IJ and Høgdall C: Type I versus type II endometrial
cancer: Differential impact of comorbidity. Int J Gynecol Cancer.
28:586–593. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhang XM, Ma ZW, Wang Q, Wang JN, Yang JW,
Li XD, Li H and Men TY: A new RNA-seq method to detect the
transcription and non-coding RNA in prostate cancer. Pathol Oncol
Res. 20:43–50. 2014. View Article : Google Scholar : PubMed/NCBI
|
